These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4195058)
1. Treatment of Gilbert's syndrome with phenobarbitone. Black M; Sherlock S Lancet; 1970 Jun; 1(7661):1359-61. PubMed ID: 4195058 [No Abstract] [Full Text] [Related]
2. [Effect of ethanol and phenobarbital on liver UDPG-transferase and on serum bilirubin in patients with Gilbert's syndrome]. Ideo G; Del Ninno E; De Franchis R; Bitto T; Colombo M Quad Sclavo Diagn; 1972 Mar; 8(1):245-52. PubMed ID: 4663753 [No Abstract] [Full Text] [Related]
3. [The pros and cons of luminal teatment of hyperbilirubinemia]. Lüders D Monatsschr Kinderheilkd (1902); 1970 Mar; 118(3):94-102. PubMed ID: 4333560 [No Abstract] [Full Text] [Related]
5. The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. Felsher BF; Rickard D; Redeker AG N Engl J Med; 1970 Jul; 283(4):170-2. PubMed ID: 5424007 [No Abstract] [Full Text] [Related]
6. [Kinetic study of unconjugated bilirubin before and after phenobarbital treatment of 10 patients with Gilbert's syndrome]. Vincenzi M; Betti R Minerva Dietol Gastroenterol; 1984; 30(1):31-5. PubMed ID: 6728222 [No Abstract] [Full Text] [Related]
7. Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconugated hyperbilirubinaemia. Hunter J; Thompson RP; Rake MO; Williams R Br Med J; 1971 May; 2(5760):497-9. PubMed ID: 4931488 [TBL] [Abstract][Full Text] [Related]
8. [The use of optimal doses of phenobarbital in the treatment of Gilbert's syndrome]. Eselev MM; Stsepuro PG Vrach Delo; 1988 Jun; (6):65-7. PubMed ID: 3047993 [No Abstract] [Full Text] [Related]
9. [Current problems in the hyperbilirubinemia of premature infants]. Rosanelli K Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):354-62. PubMed ID: 4563170 [No Abstract] [Full Text] [Related]
10. Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia. Black M; Fevery J; Parker D; Jacobson J; Billing BH; Carson ER Clin Sci Mol Med; 1974 Jan; 46(1):1-17. PubMed ID: 4204548 [No Abstract] [Full Text] [Related]
11. Constitutional hepatic dysfunction (CHD; Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Fromke VL; Miller D Medicine (Baltimore); 1972 Nov; 51(6):451-64. PubMed ID: 4564417 [No Abstract] [Full Text] [Related]
12. [Phenobarbital therapy in congenital nonhemolytic hyperbilirubinemia (Crigler-Najjar)--report of 5 cases]. Schellong G; Soennecken U Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):422-4. PubMed ID: 5093938 [No Abstract] [Full Text] [Related]
13. [The d-glucaric acid test in the evaluation of the inductive properties of phenobarbital and spironalactone]. Del Ninno E; Tornaghi G; Tripodi A; Colombo M Acta Vitaminol Enzymol; 1974; 28(5):203-6. PubMed ID: 4480343 [No Abstract] [Full Text] [Related]
14. [Proceedings: Effect of repeated administration of spironolactone, ethanol and phenobarbital on liver bilirubin UDPG-transferase in Gilbert's jaundice]. Bitto T; Mirabile V; Tornaghi GC; Del Ninno E; Chiesa G; Portaleone D; Ideo G Quad Sclavo Diagn; 1973 Mar; 9(1):357-73. PubMed ID: 4207568 [No Abstract] [Full Text] [Related]